XML 53 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Other (Income) Expense
 3 Months Ended
Mar. 31, 2015
Other Income and Expenses [Abstract]  
Other (Income) Expense
Other (income) expense consists of:

 
Three Months Ended
March 31,
($ in millions)
2015
 
2014
Development income
$
(0.4
)
 
$
(0.4
)
Acquisition-related contingencies
0.2

 
0.4

Foreign exchange and other
(0.6
)
 
0.7

 
$
(0.8
)
 
$
0.7



During both the three months ended March 31, 2015 and 2014, we recognized development income of $0.4 million within our Pharmaceutical Delivery Systems segment ("Delivery Systems"), which related to a nonrefundable customer payment of $20.0 million received in June 2013 in return for the exclusive use of SmartDose within a specific therapeutic area. As of March 31, 2015, there was $17.1 million of unearned income related to this payment, of which $1.5 million was included in other current liabilities and $15.6 million was included in other long-term liabilities. The unearned income is being recognized as development income on a straight-line basis over the remaining term of the agreement. The agreement does not include a future minimum purchase commitment from the customer.

During the three months ended March 31, 2015 and 2014, the SmartDose contingent consideration increased by $0.2 million and $0.4 million, respectively, due to the time value of money and changes made to sales projections. These adjustments are included within Delivery Systems' results.

During the three months ended March 31, 2015, we recorded foreign exchange and other income of $0.6 million, due to foreign exchange transaction gains. During the three months ended March 31, 2014, we recorded foreign exchange and other expense of $0.7 million, consisting primarily of foreign exchange transaction losses.